Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.06.19
董事会提名委员会关于聘任管理人员的审核意见
2010.06.19
关于2010年度预计日常经营性关联交易事项的公告
2010.06.19
内部问责制度（2010年6月）
2010.06.19
第一届董事会第十九次会议决议公告
2010.06.18
2010年度1-6月业绩预增公告
2010.05.25
澄清公告
2010.05.19
中国建银投资证券有限责任公司关于公司使用部分超额募集资金的保荐意见
2010.05.19
内幕信息及知情人登记和报备制度（2010年5月）
2010.05.19
关于使用部分超额募集资金归还银行贷款和补充永久性流动资金的公告
2010.05.19
重大信息内部报告制度（2010年5月）
第一页
上一页
151
152
153
154
155
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
